{"id":"https://openalex.org/W2113521932","doi":"https://doi.org/10.2967/jnumed.108.058602","title":"Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma","display_name":"Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma","publication_year":2009,"publication_date":"2009-02-17","ids":{"openalex":"https://openalex.org/W2113521932","doi":"https://doi.org/10.2967/jnumed.108.058602","mag":"2113521932","pmid":"https://pubmed.ncbi.nlm.nih.gov/19223402"},"language":"en","primary_location":{"id":"doi:10.2967/jnumed.108.058602","doi":"https://doi.org/10.2967/jnumed.108.058602","is_oa":true,"landing_page_url":"https://doi.org/10.2967/jnumed.108.058602","pdf_url":"https://jnm.snmjournals.org/content/jnumed/50/3/444.full.pdf","source":{"id":"https://openalex.org/S4210180780","display_name":"Journal of Nuclear Medicine","issn_l":"0161-5505","issn":["0161-5505","1535-5667","2159-662X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315767","host_organization_name":"Society of Nuclear Medicine and Molecular Imaging","host_organization_lineage":["https://openalex.org/P4310315767"],"host_organization_lineage_names":["Society of Nuclear Medicine and Molecular Imaging"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nuclear Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jnm.snmjournals.org/content/jnumed/50/3/444.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043569662","display_name":"Robert M. Sharkey","orcid":"https://orcid.org/0000-0003-1408-0905","observed_orcids":["https://orcid.org/0000-0003-1408-0905"]},"institutions":[{"id":"https://openalex.org/I4210131484","display_name":"Center for Molecular Medicine and Immunology","ror":"https://ror.org/03fhjvs31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210131484"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M. Sharkey","raw_affiliation_strings":["Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Belleville, New Jersey 07109, USA. rmsharkey@gscancer.org","Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Belleville, New Jersey 07109, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Belleville, New Jersey 07109, USA. rmsharkey@gscancer.org","institution_ids":["https://openalex.org/I4210131484"]},{"raw_affiliation_string":"Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Belleville, New Jersey 07109, USA","institution_ids":["https://openalex.org/I4210131484"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045775470","display_name":"Habibe Karacay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210131484","display_name":"Center for Molecular Medicine and Immunology","ror":"https://ror.org/03fhjvs31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210131484"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Habibe Karacay","raw_affiliation_strings":["Garden State Cancer Center at the Center for Molecular Medicine and Immunology , Belleville , New Jersey ;","Univ Alabama, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Garden State Cancer Center at the Center for Molecular Medicine and Immunology , Belleville , New Jersey ;","institution_ids":["https://openalex.org/I4210131484"]},{"raw_affiliation_string":"Univ Alabama, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christine R. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I4210131484","display_name":"Center for Molecular Medicine and Immunology","ror":"https://ror.org/03fhjvs31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210131484"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine R. Johnson","raw_affiliation_strings":["Garden State Cancer Center at the Center for Molecular Medicine and Immunology , Belleville , New Jersey ;","NORTHWESTERN UNIV, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Garden State Cancer Center at the Center for Molecular Medicine and Immunology , Belleville , New Jersey ;","institution_ids":["https://openalex.org/I4210131484"]},{"raw_affiliation_string":"NORTHWESTERN UNIV, Chicago, IL","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002825676","display_name":"Samuel Litwin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel Litwin","raw_affiliation_strings":["Fox Chase Cancer Center , Philadelphia , Pennsylvania ;","Mary Crowley Cancer Res Ctr, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center , Philadelphia , Pennsylvania ;","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"Mary Crowley Cancer Res Ctr, Dallas, TX","institution_ids":["https://openalex.org/I4210087725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110966471","display_name":"Edmund A. Rossi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edmund A. Rossi","raw_affiliation_strings":["IBC Pharmaceuticals, Inc. , Morris Plains , New Jersey ; and","Lack's Cancer Ctr, Grand Rapids, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IBC Pharmaceuticals, Inc. , Morris Plains , New Jersey ; and","institution_ids":[]},{"raw_affiliation_string":"Lack's Cancer Ctr, Grand Rapids, MI","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"William J. McBride","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210085997","display_name":"Florida Hospital Cancer Institute","ror":"https://ror.org/00aqz8k66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210085997"]},{"id":"https://openalex.org/I4210126919","display_name":"Immunomedics (United States)","ror":"https://ror.org/02pf50490","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William J. McBride","raw_affiliation_strings":["Immunomedics, Inc. , Morris Plains , New Jersey","Florida Hosp Cancer Ins, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunomedics, Inc. , Morris Plains , New Jersey","institution_ids":["https://openalex.org/I4210126919"]},{"raw_affiliation_string":"Florida Hosp Cancer Ins, Orlando, FL","institution_ids":["https://openalex.org/I4210085997"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109346302","display_name":"Chien\u2010Hsing Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chien-Hsing Chang","raw_affiliation_strings":["NORTHWESTERN UNIV, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NORTHWESTERN UNIV, Chicago, IL","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003890903","display_name":"David M. Goldenberg","orcid":"https://orcid.org/0000-0001-5539-421X","observed_orcids":["https://orcid.org/0000-0001-5539-421X"]},"institutions":[{"id":"https://openalex.org/I4210131484","display_name":"Center for Molecular Medicine and Immunology","ror":"https://ror.org/03fhjvs31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210131484"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M. Goldenberg","raw_affiliation_strings":["Center for Molecular Medicine and Immunology , 520 Belleville Ave. , Belleville , NJ 07109 ","Garden State Cancer Center at the Center for Molecular Medicine and Immunology , Belleville , New Jersey ;","TransMolecular Inc, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Molecular Medicine and Immunology , 520 Belleville Ave. , Belleville , NJ 07109 ","institution_ids":["https://openalex.org/I4210131484"]},{"raw_affiliation_string":"Garden State Cancer Center at the Center for Molecular Medicine and Immunology , Belleville , New Jersey ;","institution_ids":["https://openalex.org/I4210131484"]},{"raw_affiliation_string":"TransMolecular Inc, Cambridge, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.537,"has_fulltext":true,"cited_by_count":56,"citation_normalized_percentile":{"value":0.98140164,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"50","issue":"3","first_page":"444","last_page":"453"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pretargeted-radioimmunotherapy","display_name":"pretargeted radioimmunotherapy","score":0.9679999947547913},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.7940000295639038},{"id":"https://openalex.org/keywords/veltuzumab","display_name":"veltuzumab","score":0.972000002861023},{"id":"https://openalex.org/keywords/epratuzumab","display_name":"epratuzumab","score":0.7760000228881836},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.8949999809265137},{"id":"https://openalex.org/keywords/burkitt-lymphoma","display_name":"Burkitt lymphoma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/yttrium-90","display_name":"yttrium-90","score":0.7409999966621399},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.7519999742507935},{"id":"https://openalex.org/keywords/tumor-biodistribution","display_name":"tumor biodistribution","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.9695820808410645},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6942896842956543},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.6222822666168213},{"id":"https://openalex.org/C2778515704","wikidata":"https://www.wikidata.org/wiki/Q635415","display_name":"Ibritumomab tiuxetan","level":5,"score":0.5068977475166321},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4712070822715759},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4527885317802429},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3856258988380432},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29761648178100586},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.23119038343429565},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.07480710744857788},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.055893152952194214},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.05269789695739746}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000944","descriptor_name":"Antigens, Differentiation, B-Lymphocyte","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000949","descriptor_name":"Histocompatibility Antigens Class II","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D002051","descriptor_name":"Burkitt Lymphoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002051","descriptor_name":"Burkitt Lymphoma","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007205","descriptor_name":"Indium Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014183","descriptor_name":"Transplantation, Heterologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015021","descriptor_name":"Yttrium Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051918","descriptor_name":"Sialic Acid Binding Ig-like Lectin 2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2967/jnumed.108.058602","doi":"https://doi.org/10.2967/jnumed.108.058602","is_oa":true,"landing_page_url":"https://doi.org/10.2967/jnumed.108.058602","pdf_url":"https://jnm.snmjournals.org/content/jnumed/50/3/444.full.pdf","source":{"id":"https://openalex.org/S4210180780","display_name":"Journal of Nuclear Medicine","issn_l":"0161-5505","issn":["0161-5505","1535-5667","2159-662X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315767","host_organization_name":"Society of Nuclear Medicine and Molecular Imaging","host_organization_lineage":["https://openalex.org/P4310315767"],"host_organization_lineage_names":["Society of Nuclear Medicine and Molecular Imaging"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nuclear Medicine","raw_type":"journal-article"},{"id":"pmid:19223402","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19223402","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.2967/jnumed.108.058602","doi":"https://doi.org/10.2967/jnumed.108.058602","is_oa":true,"landing_page_url":"https://doi.org/10.2967/jnumed.108.058602","pdf_url":"https://jnm.snmjournals.org/content/jnumed/50/3/444.full.pdf","source":{"id":"https://openalex.org/S4210180780","display_name":"Journal of Nuclear Medicine","issn_l":"0161-5505","issn":["0161-5505","1535-5667","2159-662X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315767","host_organization_name":"Society of Nuclear Medicine and Molecular Imaging","host_organization_lineage":["https://openalex.org/P4310315767"],"host_organization_lineage_names":["Society of Nuclear Medicine and Molecular Imaging"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nuclear Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1084225250","display_name":"Targeted Therapy of B-cell Malignancies","funder_award_id":"P01CA103985","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320334509","display_name":"ImmunoMedics","ror":"https://ror.org/02pf50490"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2113521932.pdf","grobid_xml":"https://content.openalex.org/works/W2113521932.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W125344597","https://openalex.org/W1537791451","https://openalex.org/W1570727439","https://openalex.org/W1581624933","https://openalex.org/W1850839548","https://openalex.org/W1892026381","https://openalex.org/W1982626297","https://openalex.org/W1985346479","https://openalex.org/W1989091022","https://openalex.org/W2004224153","https://openalex.org/W2004903369","https://openalex.org/W2005230107","https://openalex.org/W2020764618","https://openalex.org/W2021396643","https://openalex.org/W2037596107","https://openalex.org/W2037803066","https://openalex.org/W2050704142","https://openalex.org/W2054409932","https://openalex.org/W2065239231","https://openalex.org/W2080352981","https://openalex.org/W2084493022","https://openalex.org/W2091953646","https://openalex.org/W2099087672","https://openalex.org/W2101553325","https://openalex.org/W2107586631","https://openalex.org/W2110646221","https://openalex.org/W2112893695","https://openalex.org/W2126539571","https://openalex.org/W2131748204","https://openalex.org/W2138994942","https://openalex.org/W2142611256","https://openalex.org/W2151123287","https://openalex.org/W2157158772","https://openalex.org/W2160227883","https://openalex.org/W2160575379","https://openalex.org/W2164532418","https://openalex.org/W2171004153","https://openalex.org/W2200499915","https://openalex.org/W2267583049","https://openalex.org/W2469072249","https://openalex.org/W2764370801"],"related_works":["https://openalex.org/W7097492653","https://openalex.org/W2564891902","https://openalex.org/W2589564541","https://openalex.org/W1989246891","https://openalex.org/W2138994942","https://openalex.org/W2142611256","https://openalex.org/W2580129411","https://openalex.org/W2107861907","https://openalex.org/W2080670826","https://openalex.org/W2200499915"],"abstract_inverted_index":{"UNLABELLED:":[0],"We":[1],"determined":[2],"whether":[3],"therapeutic":[4,135],"responses":[5,210,223],"using":[6],"a":[7,15,140,265],"bispecific":[8,180],"antibody":[9,181],"that":[10,74,163,241,256],"pretargeted":[11,59],"(90)Y-hapten-peptide":[12],"radioimmunotherapy":[13,60,81,110],"or":[14,38,55,62,158,168,179],"directly":[16],"radiolabeled,":[17],"humanized,":[18],"(90)Y-anti-CD20":[19],"IgG":[20,245,262],"(veltuzumab)":[21],"could":[22],"be":[23,272],"improved":[24,134],"by":[25,147],"combining":[26],"these":[27],"treatments":[28],"with":[29,52,58,76,132],"unlabeled":[30,77,165,243,260],"humanized":[31],"antibodies":[32,53,90],"against":[33,93],"CD22":[34],"(epratuzumab),":[35],"CD74":[36],"(milatuzumab),":[37],"veltuzumab.":[39],"METHODS:":[40],"Nude":[41],"mice":[42],"bearing":[43],"established":[44,94],"subcutaneous":[45],"Ramos":[46],"human":[47],"Burkitt":[48],"lymphoma":[49],"were":[50,117,211,224],"treated":[51],"alone":[54],"in":[56,127,173,203,206,218],"combination":[57],"(PT-RAIT)":[61],"radioimmunotherapy,":[63],"and":[64,82,95,109,122,190,195,217,255],"tumor":[65,183],"growth":[66,121],"was":[67,91,152,171,185],"monitored.":[68],"Biodistribution":[69,160],"studies":[70,239],"examined":[71],"the":[72,88,176,207,219,233,248,252,257],"effect":[73],"predosing":[75],"veltuzumab":[78,133,141,166,178,231],"had":[79],"on":[80],"PT-RAIT":[83,157,222],"targeting.":[84],"RESULTS:":[85],"None":[86],"of":[87,104,175,221,229,235,259],"unconjugated":[89],"effective":[92],"rapidly":[96],"growing":[97],"xenografts,":[98],"but":[99],"PT-RAIT,":[100],"at":[101,112],"approximately":[102,200],"30%":[103],"its":[105,113],"maximum":[106,114],"tolerated":[107,115],"dose,":[108,116],"alone,":[111],"able":[118],"to":[119,267],"arrest":[120],"even":[123],"entirely":[124],"ablate":[125],"tumors":[126],"some":[128],"animals.":[129],"Only":[130],"combinations":[131],"responses,":[136],"most":[137],"significantly":[138,186,214],"when":[139,164],"regimen":[142],"(weekly,":[143],"1.0":[144],"mg":[145],"followed":[146],"3":[148],"x":[149],"0.5":[150],"mg)":[151,170],"initiated":[153],"1":[154],"wk":[155],"after":[156,247],"(90)Y-veltuzumab.":[159],"data":[161],"indicated":[162],"(1.0":[167],"0.25":[169],"administered":[172,263],"advance":[174],"radiolabeled":[177],"injection,":[182],"uptake":[184,205],"reduced":[187,232],"((111)In-veltuzumab,":[188],"47%":[189],"25%,":[191],"respectively;":[192],"(111)In-hapten-peptide,":[193],"74%":[194],"49%,":[196],"respectively).":[197],"Despite":[198],"an":[199],"50%":[201],"decrease":[202],"radioactivity":[204,249],"tumor,":[208],"antitumor":[209],"not":[212],"diminished":[213],"for":[215],"(90)Y-veltuzumab,":[216],"case":[220],"improved.":[225],"However,":[226],"higher":[227],"amounts":[228],"predosed":[230],"effects":[234],"PT-RAIT.":[236],"CONCLUSION:":[237],"These":[238],"suggest":[240],"administering":[242],"anti-CD20":[244,261],"therapy":[246,270],"dose":[250],"provides":[251],"best":[253],"efficacy":[254],"amount":[258],"as":[264],"predose":[266],"anti-CD20-targeted":[268],"radionuclide":[269],"should":[271],"minimized.":[273]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":12}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}